Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 8-gingerol
1. 8-gingerol
2. 23513-08-8
3. [8]-gingerol
4. (5s)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)dodecan-3-one
5. (s)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-dodecanone
6. Lb0ijb138k
7. (s)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)dodecan-3-one
8. Chembl1095671
9. Chebi:81133
10. Unii-lb0ijb138k
11. Mfcd00877794
12. (s)-(+)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-dodecanone
13. 3-dodecanone, 5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-, (s)-(+)-
14. Schembl16488703
15. Dtxsid20178078
16. Hms3887a05
17. [8]-gingerol, Analytical Standard
18. Hy-n0447
19. Zinc1537498
20. Bdbm50317426
21. S9434
22. [8]-gingerol, >=95% (hplc)
23. Akos025311538
24. Ccg-267732
25. Ac-34322
26. As-71132
27. Cs-0008980
28. N1448
29. 3,3-dimethoxyestr-5(10)-ene-17bol
30. A14476
31. C17495
32. 462g352
33. 8-gingerol (constituent Of Ginger) [dsc]
34. Q-100299
35. Q27155091
36. (5s)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl) Dodecan-3-one
37. 3-dodecanone, 5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-, (5s)-
| Molecular Weight | 322.4 g/mol |
|---|---|
| Molecular Formula | C19H30O4 |
| XLogP3 | 4.2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 12 |
| Exact Mass | 322.21440943 g/mol |
| Monoisotopic Mass | 322.21440943 g/mol |
| Topological Polar Surface Area | 66.8 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 319 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A 8-Gingerol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 8-Gingerol, including repackagers and relabelers. The FDA regulates 8-Gingerol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 8-Gingerol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 8-Gingerol supplier is an individual or a company that provides 8-Gingerol active pharmaceutical ingredient (API) or 8-Gingerol finished formulations upon request. The 8-Gingerol suppliers may include 8-Gingerol API manufacturers, exporters, distributors and traders.
8-Gingerol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 8-Gingerol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 8-Gingerol GMP manufacturer or 8-Gingerol GMP API supplier for your needs.
A 8-Gingerol CoA (Certificate of Analysis) is a formal document that attests to 8-Gingerol's compliance with 8-Gingerol specifications and serves as a tool for batch-level quality control.
8-Gingerol CoA mostly includes findings from lab analyses of a specific batch. For each 8-Gingerol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
8-Gingerol may be tested according to a variety of international standards, such as European Pharmacopoeia (8-Gingerol EP), 8-Gingerol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (8-Gingerol USP).
LOOKING FOR A SUPPLIER?
